Summit Global Investments United Therapeutics Corp Transaction History

Summit Global Investments

  • $1.6 Billion
  • Q4 2024

A detailed history of Summit Global Investments transactions in United Therapeutics Corp stock. As of the latest transaction made, Summit Global Investments holds 36,081 shares of UTHR stock, worth $11.5 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
36,081
Previous 49,999 27.84%
Holding current value
$11.5 Million
Previous $17.9 Million 28.94%
% of portfolio
0.8%
Previous 1.14%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$348.66 - $410.0 $4.85 Million - $5.71 Million
-13,918 Reduced 27.84%
36,081 $12.7 Million
Q3 2024

Oct 31, 2024
SELL
$311.04 - $363.55 $1.14 Million - $1.33 Million
-3,672 Reduced 6.84%
49,999 $17.9 Million
Q2 2024

Jul 22, 2024
SELL
$228.26 - $319.04 $4.56 Million - $6.38 Million
-19,999 Reduced 27.15%
53,671 $17.1 Million
Q1 2024

Apr 29, 2024
BUY
$210.76 - $249.51 $9.81 Million - $11.6 Million
46,558 Added 171.72%
73,670 $16.9 Million
Q4 2023

Feb 06, 2024
BUY
$214.88 - $256.94 $2.6 Million - $3.11 Million
12,095 Added 80.54%
27,112 $5.96 Million
Q3 2023

Oct 13, 2023
BUY
$211.82 - $248.24 $3.18 Million - $3.73 Million
15,017 New
15,017 $3.39 Million
Q2 2021

Jan 28, 2022
SELL
$170.47 - $211.93 $272,752 - $339,088
-1,600 Closed
0 $0
Q1 2021

Jan 27, 2022
SELL
$153.94 - $174.85 $61,576 - $69,940
-400 Reduced 20.0%
1,600 $268,000
Q4 2020

Feb 11, 2021
BUY
$101.87 - $151.79 $203,740 - $303,580
2,000 New
2,000 $304,000

Others Institutions Holding UTHR

# of Institutions
725
Shares Held
61M
Call Options Held
123K
Put Options Held
104K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email